ROLE OF ECG IN DIAGNOSIS OF INHERITED ARRHYTHMIA SYNDROMES

  • Ružica Jurčević Kardiolog
  • Lazar Angelkov
  • Dejan Vukajlović
  • Velibor Ristić
  • Dejan Kojić
  • Milosav Tomović
  • Aleksandra Grbović
  • Miloš Babić
  • Nebojša Tasić
  • Milovan Bojić
Keywords: Key words: ECG, channelopathy, Brugada Syndrome, Long QT Syndrome

Abstract


The aim of this paper is to define role of ECG in diagnosis, prognosis and treatment of inherited arrhythmias syndromes. Brugada Syndrome diagnosis is established in presence of coved type ST-segment elevation (type 1) ≥ 2mm in ≥ 1 of the right precordial leads V1 to V2. Long QT Syndrome is diagnosed when one of factors is present: QTc ≥ 480 ms, QTc ≥ 460 ms in patients with unexplained syncope, pathogenic mutation or risk skore > 3. Polimorfic ventricular tachycardia (VT) Torsades de Pointes have specific presentation in ECG with characteristic illusion of a twisting of the QRS complex around the isoelectric baseline. ECG early repolarization pattern in patiets resuscitated from otherwise unexplained ventricular fibrillation (VF)/ polymorphic VT or in a sudden cardiac death (SCD) victims makes diagnosis of Early Repolarization Syndrome. Short QT Syndrome is diagnosed in the presence of a QTc ≤ 340ms or QTc ˂ 360ms with one or more of following factors: a pathogenic mutation, survival of a VT/VF episodes, family history of this disease and SCD in family at age ≤ 40. Catecholaminergic Polymorphic Ventricular Tachycardia has ECG appearance of bidirectional VT or polymorphic ventricular premature beats or VT induced by exercise or catecholamine.

 

 

References

1. Priori GS, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA,PACES, and AEPC in June 2013. Heart Rhythm 2013; 10(12):1932-63.
2. Rubart M, Zipes PD. Genesis of Cardiac Arrhythmias: Electrophysiological Considerations. In: Libby P, Bonow OR, Mann LD, Zipes PD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia: Saunders Elsevier 2008:727-62.

3. Brugada J, Campuzano O, Arbelo E, Brugada SG, Brugada R. Present Status of Brugada syndrome. JACC 2018; 72(9):1046-59.

4. Jurčević R, Angelkov L, Vukajlović D, Ristić V, Tomović M, Kojić D et al. Sindrom Brugada – naše prvo iskustvio. Vojnosanit Pregl 2009; 66(8):667-70.

5. Bohnen MS, Peng G, Robey SH, Terrenoire C, Iyer V, Sampson KJ et al. Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev 2017; 97(1):89-134.

6. Wilde AA, Remme AC. Therapeutic aprproaches for Long QT syndrome type 3: an update. Europace 2018; 20(2):222-4.

7. Patton KK, Ellinor TP, Ezekowitz M, Kowey P, Lubitz AS, Perez M et al. Electrocardiographic Early Repolarization. A Scientific Statement From the American Heart Association. Circulation 2016; 133:1520-9.

8. Sarquella-Brugada G, Campuzano O, Iglesias A, Grueso J, Bradley JD, Kerst G et al. Short QT and atrial fibrillation: A KCNQ1 mutation-specific disease. Late follow-up in three unrelated children. Heart Rhythm 2015; 1(4):193-7.

9. El-Battrawy I, Besler J, Liebe V, Schimpf R, Tulumen E, Rudic B et al. Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome. Am Heart Assoc 2018; 7:e010073. DOI: 10.1161/JAHA.118.010073.

10. Leenhardt A, Denjoy I, Guicheney P. Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Arrhythm Electrophysiol 2012; 5:1044-52.
Published
2020/06/17
Section
Mini pregledni članak